18F Choline PET/CT in a patient with HRPT2 mutation: Detecting parathyroid carcinoma recurrence and concomitant breast carcinoma.

Konrad Radzikowski; Gundula Rendl; Mohsen Beheshti; Christian Pirich

doi:10.1055/a-1670-9315

18F Choline PET/CT in a patient with HRPT2 mutation: Detecting parathyroid carcinoma recurrence and concomitant breast carcinoma.

Konrad Radzikowski (Erstautor/-in), Gundula Rendl (Co-Autor/-in), Mohsen Beheshti (Co-Autor/-in), Christian Pirich^* (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsklinikum für Nuklearmedizin und Endokrinologie

Publikation: Beitrag in Fachzeitschrift › Fallbericht › Begutachtung

3 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	62-64
Fachzeitschrift	NUKLEARMEDIZIN-NUCLEAR MEDICINE
Jahrgang	61
Ausgabenummer	1
DOIs	https://doi.org/10.1055/a-1670-9315
Publikationsstatus	Veröffentlicht - 2022

Zugriff auf Dokument

10.1055/a-1670-9315

Dieses zitieren

Radzikowski, K., Rendl, G., Beheshti, M., & Pirich, C. (2022). 18F Choline PET/CT in a patient with HRPT2 mutation: Detecting parathyroid carcinoma recurrence and concomitant breast carcinoma. NUKLEARMEDIZIN-NUCLEAR MEDICINE , 61(1), 62-64. https://doi.org/10.1055/a-1670-9315

Radzikowski, Konrad ; Rendl, Gundula ; Beheshti, Mohsen et al. / 18F Choline PET/CT in a patient with HRPT2 mutation: Detecting parathyroid carcinoma recurrence and concomitant breast carcinoma. in: NUKLEARMEDIZIN-NUCLEAR MEDICINE 2022 ; Jahrgang 61, Nr. 1. S. 62-64.

@article{04a2c8ec812846fd88d75ae7ef936b78,

title = "18F Choline PET/CT in a patient with HRPT2 mutation: Detecting parathyroid carcinoma recurrence and concomitant breast carcinoma.",

author = "Konrad Radzikowski and Gundula Rendl and Mohsen Beheshti and Christian Pirich",

note = "all : Paracelsus Med Univ Salzburg, Dept Nucl Med *** Endocrinol, A-31507 Salzburg, Austria",

year = "2022",

doi = "10.1055/a-1670-9315",

language = "English",

volume = "61",

pages = "62--64",

journal = "NUKLEARMEDIZIN-NUCLEAR MEDICINE ",

issn = "0029-5566",

number = "1",

}

Radzikowski, K, Rendl, G , Beheshti, M & Pirich, C 2022, '18F Choline PET/CT in a patient with HRPT2 mutation: Detecting parathyroid carcinoma recurrence and concomitant breast carcinoma.', NUKLEARMEDIZIN-NUCLEAR MEDICINE , Jg. 61, Nr. 1, S. 62-64. https://doi.org/10.1055/a-1670-9315

18F Choline PET/CT in a patient with HRPT2 mutation: Detecting parathyroid carcinoma recurrence and concomitant breast carcinoma. / Radzikowski, Konrad (Erstautor/-in); Rendl, Gundula (Co-Autor/-in); Beheshti, Mohsen (Co-Autor/-in) et al.
in: NUKLEARMEDIZIN-NUCLEAR MEDICINE , Jahrgang 61, Nr. 1, 2022, S. 62-64.

Publikation: Beitrag in Fachzeitschrift › Fallbericht › Begutachtung

TY - JOUR

T1 - 18F Choline PET/CT in a patient with HRPT2 mutation: Detecting parathyroid carcinoma recurrence and concomitant breast carcinoma.

AU - Radzikowski, Konrad

AU - Rendl, Gundula

AU - Beheshti, Mohsen

AU - Pirich, Christian

N1 - all : Paracelsus Med Univ Salzburg, Dept Nucl Med *** Endocrinol, A-31507 Salzburg, Austria

PY - 2022

Y1 - 2022

U2 - 10.1055/a-1670-9315

DO - 10.1055/a-1670-9315

M3 - Case report

C2 - 34844271

SN - 0029-5566

VL - 61

SP - 62

EP - 64

JO - NUKLEARMEDIZIN-NUCLEAR MEDICINE

JF - NUKLEARMEDIZIN-NUCLEAR MEDICINE

IS - 1

ER -

Radzikowski K, Rendl G , Beheshti M , Pirich C. 18F Choline PET/CT in a patient with HRPT2 mutation: Detecting parathyroid carcinoma recurrence and concomitant breast carcinoma. NUKLEARMEDIZIN-NUCLEAR MEDICINE . 2022;61(1):62-64. doi: 10.1055/a-1670-9315